Fe. Nashold et al., 1,25-dihydroxyvitamin D-3 treatment decreases macrophage accumulation in the CNS elf mice with experimental autoimmune encephalomyelitis, J NEUROIMM, 103(2), 2000, pp. 171-179
Sunlight, which is required for vitamin D biosynthesis, may be protective i
n multiple sclerosis (MS), due to the immunoregulatory functions of 1,25-di
hydroxyvitamin D-3 (1,25-(OH)(2)D-3), the hormonally active vitamin D metab
olite. This hypothesis provided the impetus for the experiments reported he
re investigating mechanisms whereby 1,25-(OH)(2)D-3 may inhibit murine expe
rimental autoimmune encephalomyelitis (EAE). Severe EAE was induced, 1,25-(
OH)(2)D-3 or mock treatment was administered, and clinical disease, histopa
thological disease, and encephalitogenic cells in the central nervous syste
m (CNS) were analyzed within 24-72 h of the treatment. The mock-treated mic
e remained paralyzed (stage 3 EAE) while most hormone-treated animals regai
ned the partial use of both hind limbs (stage 2 EAE) within 72 h of treatme
nt. A histopathological examination showed the hormone-treated mice had a 5
0% decrease in white matter and meningeal inflammation at 72 h post treatme
nt. A flow cytometric analysis of cell surface markers on spinal cord cells
recovered 24 h post treatment showed the mock-treated mice with EAE had ab
out 7.0 +/- 2.3 million Mac-1(+) cells/cord, whereas the hormone-treated mi
ce had about 2.1 +/- 2.6 million Mac-1(+) cells/cord, which was not signifi
cantly different from the unmanipulated control mice. Otherwise, the flow c
ytometric analysis detected no significant differences between the groups w
ith respect to CD4(+) or CD8(+) T cells or B cells or macrophages in draini
ng lymph nodes or spinal cords. These results are discussed with regard to
possible fates for the 5 million Mac-1(+) cells that were rapidly lost from
the inflamed CNS in the 1,25-(OH)(2)D-3-treated mice, and the possible ben
eficial effect of hormone treatment in resolving acute MS. (C) 2000 Elsevie
r Science B.V. All rights reserved.